Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis

Journal of Pediatric Hematology/Oncology

Volumn 18, Issue 4, 1996, Pages 340-345

  Egeler, R Maarten ^a,b   Shapiro, Ralph ^a,c   Loechelt, Brett ^a,d   Filipovich, Alexandra ^a,e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Cytotoxic T cell; Familial erythrophagocytic lymphohistiocytosis; Familial hemophagocytic lymphohistiocytosis; Hemophagocytic lymphohistiocytosis; Natural killer cell

Indexed keywords

ARTICLE; CHILD; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; EARLY DIAGNOSIS; FAMILIAL DISEASE; FEMALE; HEMOPHAGOCYTIC SYNDROME; HISTIOCYTOSIS; HUMAN; IMMUNOPATHOLOGY; IMMUNOPHENOTYPING; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL;

ANTIGENS, SURFACE; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; IMMUNITY, CELLULAR; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MALE; T-LYMPHOCYTES;

EID: 0029862128     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199611000-00002     Document Type: Article

References (23)

1. Farquhar JW, Claireaux AF. Familial hemophagocytic reticulosis. Arch Dis Child 1952;27:519-25.
2. Risdall RJ, McKenna RW, Nesbit ME, et al. Virus-associated hemophagocytic syndrome; a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979;44:992-1002.
3. Henter J-I, Soder O, Ost A, Elinder G. Incidence and clinical features of familial hemophagocytic lymphohistiocytosis in Sweden. Acta Paediatr Scand 1991;80:428-35.
4. Ambruso DR, Hays T, Zwartjes WJ, Tubergen D, Favara B. Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP16-213. Cancer 1980;45:2516-20.
5. Henter JI, Elinder G, Soder O, Ost A. Successful induction with chemotherapy including teniposide in familial erythrophagocytic lymphohistiocytosis. Lancet 1986;2:1402.
6. Loechelt BJ, Egeler RM, Filipovich AH, Jyonouchi H, Shapiro RS. Immunosuppression: an alternative maintenance therapy for familial hemophagocytic lymphohistiocytosis (FHL) - preliminary results. Med Pediatr Oncol 1994;22:325-8.
7. Henter JI, Elinder G, Ost A, FHL Study Group of the Histiocyte Society. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol 1991;18:29-33.
8. Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 1983;140:221-30.
9. Stark B, Cohen IJ, Pecht M, et al. Immunologic dysregulation in a patient with familial hemophagocytic lymphohistiocytosis. Cancer 1987;60:2629-36.
10. Zuazu JP, Duran JW, Julia AF. Hemophagocytosis in acute brucellosis. N Engl J Med 1979;301:1185-6.
11. Risdall RJ, Brunning RD, Hemandez JI, Gordon DH. Bacteria-associated hemophagocytic syndrome. Cancer 1984;54:2968-72.
12. Jaffe ES, Costa J, Fauci AS, Cossman J, Tsokos M. Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Am J Med 1983;75:741-9.
13. Holtman H, Janka GE, Weidner E, Eife R. Impaired natural killer cell function in familial hemophagocytic lymphohistiocytosis. Immunobiology 1982;162:364-71.
14. Perez N, Virelizier JL, Arenazana-Seisdedos F, Fischer A, Griscelli C. Impaired natural killer activity in lymphohistiocytosis syndrome. J Pediatr 1984;104:469-573.
15. Arico M, Nespoli L, Maccario R, et al. Natural cytotoxicity impairment in familial hemophagocytic lymphohistiocytosis. Arch Dis Child 1988;63:292-6.
16. Kataoka Y, Todo S, Rorioka Y, et al. Impaired natural killer activity and expression of interleukin-2 receptor antigen in familial erythrophagocytic lymphohistiocytosis. Cancer 1990;65:1937-41.
17. Eife R, Janka GE, Belohradsky BH, Holtmann H. Natural killer cell function and interferon production in familial hemophagocytic lymphohistiocytosis. Pediatr Hematol Oncol 1989;6:265-72.
18. McClain K, Gehrz R, Grierson H, Purtilo D, Filipovich A. Virus-associated histiocytic proliferations in children. Frequent association with Epstein-Barr virus and congenital or acquired immunodeficiencies. Am J Pediatr Hematol Oncol 1988;10:196-205.
19. Ladisch S, Poplack DG, Holiman B, Blaese RM. Immunodeficiency in familial hemophagocytic lymphohistiocytosis. Lancet 1978;1: 581-3.
20. Komp DM, McNamara J, Buckley P. Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood 1989;73:2128-32.
21. Henter JI, Elinder G, Soder O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991;78:2918-22.
22. Howells DW, Strobel S, Smith I, Levinsky RJ, Hyland K. Central nervous system involvement in the erythrophagocytic disorder of infancy: the role of cerebrospinal fluid neopterins in their differential diagnosis and clinical management. Pediatr Res 1990;28: 116-99.
23. Henter JI, Elinder G. Cerebromeningeal hemophagocytic lymphohistiocytosis. Lancet 1992;1339:104-7.